Virtual Library

Start Your Search

T. Murakawa



Author of

  • +

    P2.02 - Poster Session/ Treatment of Localized Disease – NSCLC (ID 210)

    • Event: WCLC 2015
    • Type: Poster
    • Track: Treatment of Localized Disease - NSCLC
    • Presentations: 1
    • +

      P2.02-002 - Impact of Multiple Cancer Treatment History on Outcome in Patients with Surgically Resected Non-Small Cell Lung Cancer (ID 841)

      09:30 - 17:00  |  Author(s): T. Murakawa

      • Abstract
      • Slides

      Background:
      It has been common that patients with previous cancer treatment history undergo curative resection of non-small cell lung cancer (NSCLC); however, the impact of multiple cancer history on outcome after surgery remains unclear.

      Methods:
      We conducted a retrospective study by using data from patients who underwent curative surgical resection for NSCLC between 1998 and 2011 at our institution. Data recorded for analyses were: age, gender, clinical and pathological stages of NSCLC, mode of surgical resection, comorbidities, pre-treatment serum CEA level, smoking history, and previous cancer history (organ, histologic type, number of cancer treated). The chi-square test and Wilcoxon test were used to analyze the factors between groups (ie, cases with previous cancer history versus those without cancer history). The Kaplan-Meier method was used to estimate survival rates. The log-rank test was applied to compare the survival rates between the groups. A p value less than 0.05 was considered as statistically significant.

      Results:
      In the study, 229 out of 923 cases (24.8%) had previous cancer treatment history. In the 229 cases, 194 had single cancer treatment history, 30 had double cancer treatment history, and 5 had triple cancer treatment history. Types of cancer treated were: colorectal cancer (n=51), lung cancer (n=30), hepatocellular carcinoma (n=25), breast cancer (n=16), esophageal cancer (n=15), renal cell cancer (n=12), cancers of head and neck (n=11), and others (n=56). There were significantly increased rate of having cancer treatment history in the later study period (2005-2011) compared to a rate in the earlier study period (1998-2004)(30% versus 15%, p<0.01). When comparing to patients without previous cancer history, those with previous cancer history were significantly older (69.1 versus 66.4 years, p<0.01), and had higher smoking history rate (75.1% versus 64.7%, p<0.01). On the other hand, the proportion of stage I NSCLC was significantly higher in cases with previous cancer history than those without previous cancer history (95.2% versus 74.4%, p<0.01). All cases with triple cancer treatment history had clinical and pathological stage I NSCLCs. The survival outcome after surgical resection was significantly better in cases without previous cancer treatment history than those with cancer treatment history (5-year survival rates; 79% versus 75%). In those with cancer treatment history, cases with 2 or more cancers treated had worse outcome than those with only one cancer treated before lung cancer resection (5-year survival rates; 69% versus 76%).

      Conclusion:
      Although the previous cancer treatment history and the number of cancers treated affected the outcome of patients who underwent curative lung cancer resection, the 5-year survival rate of 75% was achieved in the population. In those with previous cancer history, lung cancer tends to be found in early stage because of the periodical check-up for previous cancers. Therefore, surgical resection of newly detected NSCLC can be a viable option, if the previously treated cancer(s) are well controlled and the new lung cancer is deemed resectable.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.